NCT07215754View on ClinicalTrials.gov

Real World Evidence of Anifrolumab in Systemic Lupus Erythematosus: Investigator Initiated, Observational, Multicenter Study Evaluating Effectiveness and Safety of Anifrolumab in Active SLE Patients

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

May 25, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2031

Conditions
Systemic Lupus Erythematosus
Trial Locations (1)

56100

RECRUITING

University of Pisa, Pisa

All Listed Sponsors
lead

University of Pisa

OTHER